Onkure Therapeutics, Stock Buy Hold or Sell Recommendation
| OKUR Stock | 8.38 0.33 4.10% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding OnKure Therapeutics, is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated analysis based on historical performance and your stated risk tolerance. It serves as guidance on whether to purchase or sell OnKure Therapeutics, within the specified time frame.
Check out OnKure Therapeutics, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in OnKure Stock, please use our How to Invest in OnKure Therapeutics, guide. Note, we conduct extensive research on individual companies such as OnKure and provide practical buy, sell, or hold advice based on investors' constraints. OnKure Therapeutics,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.
OnKure |
Execute OnKure Therapeutics, Buy or Sell Advice
The OnKure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on OnKure Therapeutics,. Macroaxis does not own or have any residual interests in OnKure Therapeutics, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute OnKure Therapeutics,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
OnKure Therapeutics, Trading Alerts and Improvement Suggestions
| OnKure Therapeutics, generated a negative expected return over the last 90 days | |
| OnKure Therapeutics, has high historical volatility and very poor performance | |
| OnKure Therapeutics, has a very high chance of going through financial distress in the upcoming years | |
| OnKure Therapeutics, was previously known as Reneo Pharmaceuticals and was traded on NASDAQ Exchange under the symbol RPHM. | |
| Net Loss for the year was (35.31 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| OnKure Therapeutics, has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from globenewswire.com: OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic Data from its First-In-Human PIKture-01 Trial of OKI-219 |
OnKure Therapeutics, Returns Distribution Density
The distribution of OnKure Therapeutics,'s historical returns is an attempt to chart the uncertainty of OnKure Therapeutics,'s future price movements. The chart of the probability distribution of OnKure Therapeutics, daily returns describes the distribution of returns around its average expected value. We use OnKure Therapeutics, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of OnKure Therapeutics, returns is essential to provide solid investment advice for OnKure Therapeutics,.
| Mean Return | -0.79 | Value At Risk | -8.47 | Potential Upside | 5.88 | Standard Deviation | 4.32 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of OnKure Therapeutics, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
OnKure Therapeutics, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to OnKure Therapeutics, or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that OnKure Therapeutics,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a OnKure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.81 | |
β | Beta against Dow Jones | 0.23 | |
σ | Overall volatility | 4.26 | |
Ir | Information ratio | -0.19 |
OnKure Therapeutics, Volatility Alert
OnKure Therapeutics, exhibits very low volatility with skewness of -0.32 and kurtosis of 0.12. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure OnKure Therapeutics,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact OnKure Therapeutics,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.OnKure Therapeutics, Fundamentals Vs Peers
Comparing OnKure Therapeutics,'s fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze OnKure Therapeutics,'s direct or indirect competition across all of the common fundamentals between OnKure Therapeutics, and the related equities. This way, we can detect undervalued stocks with similar characteristics as OnKure Therapeutics, or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of OnKure Therapeutics,'s fundamental indicators could also be used in its relative valuation, which is a method of valuing OnKure Therapeutics, by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare OnKure Therapeutics, to competition |
| Fundamentals | OnKure Therapeutics, | Peer Average |
| Net Income | (35.31 M) | 570.98 M |
| Total Debt | 137.58 M | 5.32 B |
| Total Asset | 35.73 M | 29.47 B |
| Retained Earnings | (102.05 M) | 9.33 B |
| Working Capital | 26.48 M | 1.48 B |
| Net Asset | 35.73 M |
Note: Acquisition by Jansen Valerie Malyvanh of 15300 shares of OnKure Therapeutics, at 18.2 subject to Rule 16b-3 [view details]
OnKure Therapeutics, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as OnKure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About OnKure Therapeutics, Buy or Sell Advice
When is the right time to buy or sell OnKure Therapeutics,? Buying financial instruments such as OnKure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having OnKure Therapeutics, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run World Allocation Funds Thematic Idea Now
World Allocation Funds
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.